- Home
- SUUN vs RPTX Comparison
SUUN vs RPTX Comparison
Compare SUUN & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUUN
- RPTX
- Stock Information
- Founded
- SUUN 2013
- RPTX 2016
- Country
- SUUN Canada
- RPTX Canada
- Employees
- SUUN N/A
- RPTX N/A
- Industry
- SUUN
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- SUUN
- RPTX Health Care
- Exchange
- SUUN Nasdaq
- RPTX Nasdaq
- Market Cap
- SUUN 68.9M
- RPTX 78.2M
- IPO Year
- SUUN N/A
- RPTX 2020
- Fundamental
- Price
- SUUN $1.69
- RPTX $1.79
- Analyst Decision
- SUUN Strong Buy
- RPTX Strong Buy
- Analyst Count
- SUUN 2
- RPTX 3
- Target Price
- SUUN $5.00
- RPTX $3.50
- AVG Volume (30 Days)
- SUUN 401.8K
- RPTX 197.0K
- Earning Date
- SUUN 11-13-2025
- RPTX 11-07-2025
- Dividend Yield
- SUUN N/A
- RPTX N/A
- EPS Growth
- SUUN N/A
- RPTX N/A
- EPS
- SUUN N/A
- RPTX N/A
- Revenue
- SUUN $30,451,073.00
- RPTX $250,000.00
- Revenue This Year
- SUUN $86.31
- RPTX N/A
- Revenue Next Year
- SUUN $24.16
- RPTX N/A
- P/E Ratio
- SUUN N/A
- RPTX N/A
- Revenue Growth
- SUUN N/A
- RPTX N/A
- 52 Week Low
- SUUN $1.23
- RPTX $0.89
- 52 Week High
- SUUN $6.43
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- SUUN 43.70
- RPTX 46.12
- Support Level
- SUUN $1.71
- RPTX $1.74
- Resistance Level
- SUUN $1.99
- RPTX $1.97
- Average True Range (ATR)
- SUUN 0.19
- RPTX 0.09
- MACD
- SUUN -0.03
- RPTX -0.01
- Stochastic Oscillator
- SUUN 3.65
- RPTX 23.40
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.